February - 2022
| Previous Next | Showing Journal 2 of 8 |
Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane OxygenationB Levy, N Girerd, J Amour, et al for the HYPO-ECMO Trial Group and the International ECMO Network (ECMONet) JAMA, 2022, February 2022 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
February |
Previous Comments
No Comments yet.
Comment
The increasingly “routine” use of VA ECMO for cardiogenic shock and cardiac arrest leads to obvious questions about efficacy, but also questions about best supporting therapies. As an example is the use of hypothermia as an adjunct, for neurological and inflammatory...